Stock research

VCYT Veracyte, Inc.

Healthcare • Medical - Diagnostics & Research

$59.78
4.07 (—%)

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers...…

ALL change

+36.05%

Range high

$60.49

Congress · 90d

0

Insiders · 90d

0

Public signal layer

Who is disclosing activity in VCYT?

Latest linked filings in Indy

Congress

View all
GC Gilbert Ray Cisneros $1,001 - $15,000 PURCHASE Feb. 18, 2026
GC Gilbert Ray Cisneros $1,001 - $15,000 SALE (PARTIAL) Nov. 12, 2025
GC Gilbert Ray Cisneros $1,001 - $15,000 PURCHASE Jun. 16, 2025

Corporate insiders

View all

No insider transactions yet.

Price

Hover to inspect price

Showing ALL history. Source: FMP historical price full.

Prev Close
$55.71
Day High
$59.92
Day Low
$54.73
52w High
$60.91
52w Low
$22.92
Volume
1,482,438
Avg Volume
Beta
1.934

* TTM/most recent where available

Company

Ticker
VCYT
Exchange
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
US
CEO
Marc Stapley
Employees
755
Website
www.veracyte.com

Key Metrics

Market Cap
4.77B
P/E
P/B
P/S
EV/EBITDA
ROE
Net Margin
Div Yield
FCF/Share

* TTM/most recent where available

DCF Valuation

↑ Above DCF 54.2%

Standard DCF

$38.78 as of Jul. 30, 2026

Levered DCF

$41.03 as of Jul. 30, 2026

Market Price

$59.78 vs DCF 54.2%

DCF vs Price (30D window)

Price uses last 30 days; DCF line holds latest value across the window.

DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).